KK
UTHR icon

KLP Kapitalforvaltning’s United Therapeutics UTHR Stock Holding History

KLP Kapitalforvaltning’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Buy
22,680
+520
+2% +$293K 0.04% 354
2026
Q1 		$13.1M Buy
22,160
+160
+0.7% +$79.7K 0.05% 308
2025
Q4 		$10.7M Hold
22,000
– – 0.04% 349
2025
Q3 		$9.22M Sell
22,000
-37,900
-63% -$12.7M 0.04% 376
2025
Q2 		$17.2M Buy
59,900
+300
+0.5% +$89.7K 0.07% 250
2025
Q1 		$18.4M Buy
59,600
+16,300
+38% +$5.59M 0.09% 226
2024
Q4 		$15.3M Buy
+43,300
New +$15.9M 0.07% 267

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

KLP Kapitalforvaltning's UTHR Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its United Therapeutics (UTHR) stake by 2.3% in Q2 2026, buying an estimated $293K and bringing the position to 22,680 shares worth $12.3M. The position accounts for 0.04% of the portfolio, ranked #354.

KLP Kapitalforvaltning first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.4M in Q1 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • KLP Kapitalforvaltning held 22,680 shares of United Therapeutics worth $12.3M as of Q2 2026.
  • KLP Kapitalforvaltning bought 520 United Therapeutics shares in Q2 2026, an estimated $293K.
  • United Therapeutics made up 0.04% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #354 holding.
  • KLP Kapitalforvaltning first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's United Therapeutics position peaked at $18.4M in Q1 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.